Viewing Study NCT02240667


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-18 @ 1:30 PM
Study NCT ID: NCT02240667
Status: COMPLETED
Last Update Posted: 2019-04-19
First Post: 2014-09-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-09-18
Start Date Type: ACTUAL
Primary Completion Date: 2017-12-31
Primary Completion Date Type: ACTUAL
Completion Date: 2017-12-31
Completion Date Type: ACTUAL
First Submit Date: 2014-09-15
First Submit QC Date: None
Study First Post Date: 2014-09-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-12-20
Results First Submit QC Date: None
Results First Post Date: 2019-04-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-04-18
Last Update Post Date: 2019-04-19
Last Update Post Date Type: ACTUAL